Back

Latest Forum Topics / UGHealthcare    Last:0.084    +0.003

Post Reply

UGHealthcare share worth keeping? Post Reply Rate topic
Everyday Elite	01-Sep-2021 13:27        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	Open at 0.535 and now 0.530 as at 1.24pm..416k shares changed hands.....based on recent two analyst views the target price was 0.570 and 0.650  There is room for current price to progress...we  UG shares holders hv to wait patiently and collect some dividends...0.5 cents is better than none.....it takes time for the tree to bear fruits Riverstone recovered to 1.27 and Top Glove to 1.28.. .. the mood among  the Glove counters is improving...
Useful To Me  Not Useful To Me
Richardlai Master	01-Sep-2021 11:36        Richardlai About Contact  Quote this Post!
x 0   x 0  Alert Admin	UG once able to produce and deliver larger volume of gloves should be able to do well and offset the effects of reduced sale prices. For the moment I do not think the price may go anywhere untill the selling is fully absorbed. Meanwhile it can keep on building up its cash reserves !
Useful To Me  Not Useful To Me
DeepBlue Veteran	01-Sep-2021 09:50        DeepBlue About Contact  Quote this Post!
x 0   x 0  Alert Admin	Job is to create volitility in order to add position. Everyday      ( Date: 01-Sep-2021 07:21) Posted: Thanks for the report...the target price was stated as 0.57 & 0.65 Current price is only 0.535...still can go up some more Also analysts are not always right...anything can change in the future Besides the 3rd factory to be ready in Mar 2022 will boost production by 1.2B & cash balance went up fr 50m to 68m were not mentioned.These were missed out. See how the mkt respond.... PhillipTan      ( Date: 01-Sep-2021 01:10) Posted: Analysts mixed on UG Healthcare as glove prices decline Analysts from CGS-CIMB Research and RHB Group Research are mixed on UG Healthcare despite posting a " solid" set of results for its FY2021 ended June. CGS-CIMB has kept its " add" call but slashed its target price from $1.20 to 65 cents. Meanwhile, RHB kept its " neutral" rating and target price of 57 cents unchanged. CGS-CIMB analyst Ong Khang Chuen notes that UG Healthcare' s FY2021 earnings of $118.8 million were in line with his expectations. However, he notes that on a q-o-q basis, UG Healthcare' s revenue fell 14%, as end-customers turned more cautious on procurement in view of the downtrend in average selling prices (ASPs) for gloves. Ong believes that glove ASPs peaked in March and will further decline in the near term - he estimates ASPs to fall some 30% q-o-q in 1QFY2022, driven by increasing price competition on the back of higher glove supply capacity globally. In addition, cautiousness in inventory procurement by distributors and end-customers given the frequent price adjustments over the past half-year will also likely contribute to the decline in ASPs. To that end, Ong has lowered his year-end ASP assumptions to US$40, US$26 and US$25 for 2021, 2022 and 2023 respectively. However, he believes that UG Healthcare' s ASPs can be more resilient compared to peers, given its diverse product mix and strong downstream distribution network especially in emerging markets such as Africa and South America where international peers are less entrenched. In addition, Ong highlights that while the enhanced movement control order (EMCO) in Seremban impacted UGHC' s production output in July and August, he believes the company can continue to maintain " flattish" sales volume growth in 1HFY2022 due to its investory buffer and a boost in production capacity by 500 million pieces per annum in April. His lower target price of 65 cents is underpinned by a switch to a P/E valuation methodology to account for near-term risks with ASP volatility. His target price is based on a 2023 P/E of 11.2 times, which reflects a 30% discount to the glove sector' s historical mean. Ong believes UG Healthcare' s valuation is undemanding at 6.1 times 2022 P/E, supported by net cash of $49.8 million which makes up around 15% of the company' s market capitalisation. Meanwhile, RHB' s Singapore research team highlights that UG Healthcare' s FY2021 earnings beat their expectations, driven by higher-than-expected ASPs. Nevertheless, similar to Ong, the team expects weaker ASPs in the near term. " We believe that long-term gloves consumption growth remains solid due to higher hygiene awareness globally. However, we believe that ASP peaked in 1Q2021 due to rising competition from new supply of gloves in the market. Note that major gloves producers in Malaysia have guided for lower ASP for the next few months," the team explains. The team has kept its forecasts unchanged and reiterate its " neutral" rating. However, the team also notes that UG Healthcare' s balance sheet is strong with net cash of $53 million or 8.6 cents per share. Shares in UG Healthcare closed 2 cents or 3.6% lower at 53.5 cents on August 31.
Useful To Me  Not Useful To Me
Everyday Elite	01-Sep-2021 07:21        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	Thanks for the report...the target price was stated as 0.57 & 0.65 Current price is only 0.535...still can go up some more Also analysts are not always right...anything can change in the future Besides the 3rd factory to be ready in Mar 2022 will boost production by 1.2B & cash balance went up fr 50m to 68m were not mentioned.These were missed out. See how the mkt respond.... PhillipTan      ( Date: 01-Sep-2021 01:10) Posted: Analysts mixed on UG Healthcare as glove prices decline Analysts from CGS-CIMB Research and RHB Group Research are mixed on UG Healthcare despite posting a " solid" set of results for its FY2021 ended June. CGS-CIMB has kept its " add" call but slashed its target price from $1.20 to 65 cents. Meanwhile, RHB kept its " neutral" rating and target price of 57 cents unchanged. CGS-CIMB analyst Ong Khang Chuen notes that UG Healthcare' s FY2021 earnings of $118.8 million were in line with his expectations. However, he notes that on a q-o-q basis, UG Healthcare' s revenue fell 14%, as end-customers turned more cautious on procurement in view of the downtrend in average selling prices (ASPs) for gloves. Ong believes that glove ASPs peaked in March and will further decline in the near term - he estimates ASPs to fall some 30% q-o-q in 1QFY2022, driven by increasing price competition on the back of higher glove supply capacity globally. In addition, cautiousness in inventory procurement by distributors and end-customers given the frequent price adjustments over the past half-year will also likely contribute to the decline in ASPs. To that end, Ong has lowered his year-end ASP assumptions to US$40, US$26 and US$25 for 2021, 2022 and 2023 respectively. However, he believes that UG Healthcare' s ASPs can be more resilient compared to peers, given its diverse product mix and strong downstream distribution network especially in emerging markets such as Africa and South America where international peers are less entrenched. In addition, Ong highlights that while the enhanced movement control order (EMCO) in Seremban impacted UGHC' s production output in July and August, he believes the company can continue to maintain " flattish" sales volume growth in 1HFY2022 due to its investory buffer and a boost in production capacity by 500 million pieces per annum in April. His lower target price of 65 cents is underpinned by a switch to a P/E valuation methodology to account for near-term risks with ASP volatility. His target price is based on a 2023 P/E of 11.2 times, which reflects a 30% discount to the glove sector' s historical mean. Ong believes UG Healthcare' s valuation is undemanding at 6.1 times 2022 P/E, supported by net cash of $49.8 million which makes up around 15% of the company' s market capitalisation. Meanwhile, RHB' s Singapore research team highlights that UG Healthcare' s FY2021 earnings beat their expectations, driven by higher-than-expected ASPs. Nevertheless, similar to Ong, the team expects weaker ASPs in the near term. " We believe that long-term gloves consumption growth remains solid due to higher hygiene awareness globally. However, we believe that ASP peaked in 1Q2021 due to rising competition from new supply of gloves in the market. Note that major gloves producers in Malaysia have guided for lower ASP for the next few months," the team explains. The team has kept its forecasts unchanged and reiterate its " neutral" rating. However, the team also notes that UG Healthcare' s balance sheet is strong with net cash of $53 million or 8.6 cents per share. Shares in UG Healthcare closed 2 cents or 3.6% lower at 53.5 cents on August 31.
Useful To Me  Not Useful To Me
PhillipTan Supreme	01-Sep-2021 01:10        PhillipTan About Contact  Quote this Post!   Mood:
x 0   x 0  Alert Admin	Analysts mixed on UG Healthcare as glove prices decline Analysts from CGS-CIMB Research and RHB Group Research are mixed on UG Healthcare despite posting a " solid" set of results for its FY2021 ended June. CGS-CIMB has kept its " add" call but slashed its target price from $1.20 to 65 cents. Meanwhile, RHB kept its " neutral" rating and target price of 57 cents unchanged. CGS-CIMB analyst Ong Khang Chuen notes that UG Healthcare' s FY2021 earnings of $118.8 million were in line with his expectations. However, he notes that on a q-o-q basis, UG Healthcare' s revenue fell 14%, as end-customers turned more cautious on procurement in view of the downtrend in average selling prices (ASPs) for gloves. Ong believes that glove ASPs peaked in March and will further decline in the near term - he estimates ASPs to fall some 30% q-o-q in 1QFY2022, driven by increasing price competition on the back of higher glove supply capacity globally. In addition, cautiousness in inventory procurement by distributors and end-customers given the frequent price adjustments over the past half-year will also likely contribute to the decline in ASPs. To that end, Ong has lowered his year-end ASP assumptions to US$40, US$26 and US$25 for 2021, 2022 and 2023 respectively. However, he believes that UG Healthcare' s ASPs can be more resilient compared to peers, given its diverse product mix and strong downstream distribution network especially in emerging markets such as Africa and South America where international peers are less entrenched. In addition, Ong highlights that while the enhanced movement control order (EMCO) in Seremban impacted UGHC' s production output in July and August, he believes the company can continue to maintain " flattish" sales volume growth in 1HFY2022 due to its investory buffer and a boost in production capacity by 500 million pieces per annum in April. His lower target price of 65 cents is underpinned by a switch to a P/E valuation methodology to account for near-term risks with ASP volatility. His target price is based on a 2023 P/E of 11.2 times, which reflects a 30% discount to the glove sector' s historical mean. Ong believes UG Healthcare' s valuation is undemanding at 6.1 times 2022 P/E, supported by net cash of $49.8 million which makes up around 15% of the company' s market capitalisation. Meanwhile, RHB' s Singapore research team highlights that UG Healthcare' s FY2021 earnings beat their expectations, driven by higher-than-expected ASPs. Nevertheless, similar to Ong, the team expects weaker ASPs in the near term. " We believe that long-term gloves consumption growth remains solid due to higher hygiene awareness globally. However, we believe that ASP peaked in 1Q2021 due to rising competition from new supply of gloves in the market. Note that major gloves producers in Malaysia have guided for lower ASP for the next few months," the team explains. The team has kept its forecasts unchanged and reiterate its " neutral" rating. However, the team also notes that UG Healthcare' s balance sheet is strong with net cash of $53 million or 8.6 cents per share. Shares in UG Healthcare closed 2 cents or 3.6% lower at 53.5 cents on August 31.
Useful To Me  Not Useful To Me
Everyday Elite	31-Aug-2021 18:24        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	Closed at 0.535..... Everyday      ( Date: 31-Aug-2021 16:36) Posted: Today 0.540 is a famous number....fr morn to aftn Hope for price recovery... Internet very slow in the World Dream Cruise ship....tmr I will be back
Useful To Me  Not Useful To Me
Everyday Elite	31-Aug-2021 16:36        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	Today 0.540 is a famous number....fr morn to aftn Hope for price recovery... Internet very slow in the World Dream Cruise ship....tmr I will be back
Useful To Me  Not Useful To Me
Midtermer Master	31-Aug-2021 10:12        Midtermer About Contact  Quote this Post!
x 0   x 0  Alert Admin	Looks like it closed the gap to 530. Let's see if it turns from here. W2 support should be around 520. Dyodd.
Useful To Me  Not Useful To Me
DeepBlue Veteran	30-Aug-2021 21:01        DeepBlue About Contact  Quote this Post!
x 0   x 0  Alert Admin	Litmus test at $0.59.
Useful To Me  Not Useful To Me
tritonyeah6666 Senior	30-Aug-2021 19:24        tritonyeah6666 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Closed day high. Hope it is a good sign
Useful To Me  Not Useful To Me
Everyday Elite	30-Aug-2021 18:13        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	Yes...having Chinese set dinner now onboard Dream Cruise 1700 guests young and old...enjoying...all passed Covid Test before we board on Sun. DeepBlue      ( Date: 30-Aug-2021 16:54) Posted: Trading on board a cruise. Nice. Everyday      ( Date: 30-Aug-2021 16:03) Posted: Indeed price dropped for a while but quickly recovered to 0.55
Useful To Me  Not Useful To Me
Everyday Elite	30-Aug-2021 18:09        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	Let's see by end of this week whether it can cross 60 cents.. We still hv tmr to Fri......can price hold & go up? we are hopeful ...live one day at a time...☝ The ball is in the hands of the market players..
Useful To Me  Not Useful To Me
cherintc Senior	30-Aug-2021 17:50        cherintc About Contact  Quote this Post!
x 0   x 0  Alert Admin	There is a small gap up, but today gain and volume not enough to change the outlook, still is downtrend.
Useful To Me  Not Useful To Me
DeepBlue Veteran	30-Aug-2021 16:54        DeepBlue About Contact  Quote this Post!
x 0   x 0  Alert Admin	Trading on board a cruise. Nice. Everyday      ( Date: 30-Aug-2021 16:03) Posted: Indeed price dropped for a while but quickly recovered to 0.555 Everyday      ( Date: 30-Aug-2021 15:29) Posted: No signs of attack yet....the market players hv a standby battalion ready....
Useful To Me  Not Useful To Me
Everyday Elite	30-Aug-2021 16:03        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	Indeed price dropped for a while but quickly recovered to 0.555 Everyday      ( Date: 30-Aug-2021 15:29) Posted: No signs of attack yet....the market players hv a standby battalion ready.... tritonyeah6666      ( Date: 30-Aug-2021 13:37) Posted: I think shortist may try their luck to attack since it didn't quite shoot up after the 8 folds earning announcemen
Useful To Me  Not Useful To Me
Everyday Elite	30-Aug-2021 15:29        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	No signs of attack yet....the market players hv a standby battalion ready.... tritonyeah6666      ( Date: 30-Aug-2021 13:37) Posted: I think shortist may try their luck to attack since it didn't quite shoot up after the 8 folds earning announcement Everyday      ( Date: 30-Aug-2021 11:49) Posted: 👍 👍 Hope for the bes
Useful To Me  Not Useful To Me
tritonyeah6666 Senior	30-Aug-2021 13:37        tritonyeah6666 About Contact  Quote this Post!
x 0   x 0  Alert Admin	I think shortist may try their luck to attack since it didn't quite shoot up after the 8 folds earning announcement Everyday      ( Date: 30-Aug-2021 11:49) Posted: 👍 👍 Hope for the best Midtermer      ( Date: 30-Aug-2021 11:36) Posted: TA wise if 535/540 holds, good chance to go 580 / 585 soon. Cheer
Useful To Me  Not Useful To Me
Everyday Elite	30-Aug-2021 11:49        Everyday About Contact  Quote this Post!
x 0   x 0  Alert Admin	👍 👍 Hope for the best Midtermer      ( Date: 30-Aug-2021 11:36) Posted: TA wise if 535/540 holds, good chance to go 580 / 585 soon. Cheers Everyday      ( Date: 30-Aug-2021 10:13) Posted: Let the market players decide the price... We hv no control...Up is better than down.Last Fri was '0 525.. One day at a time....☝ ☝
Useful To Me  Not Useful To Me
Midtermer Master	30-Aug-2021 11:36        Midtermer About Contact  Quote this Post!
x 0   x 0  Alert Admin	TA wise if 535/540 holds, good chance to go 580 / 585 soon. Cheers Everyday      ( Date: 30-Aug-2021 10:13) Posted: Let the market players decide the price... We hv no control...Up is better than down.Last Fri was '0 525.. One day at a time....☝ ☝
Useful To Me  Not Useful To Me
Midtermer Master	30-Aug-2021 11:01        Midtermer About Contact  Quote this Post!
x 0   x 0  Alert Admin	I think the company is very conservative on the use of cash as they are looking to expand. I'm also not aware they have SBB policy in place for now. Dyodd. Richardlai      ( Date: 30-Aug-2021 10:46) Posted: Make hay while the sun shines ! Hopefully the company starts buying their own shares since they have plenty of cash lying around unused. Everyday      ( Date: 30-Aug-2021 09:19) Posted: I am on Cruise since yesterday on World Dream..now in South China sea.. Mobile data switched off & now on Ship's internet...read in Google..price went up... to 0.560.....cheers to all UG share holders....will be back on Wed...😁 😁
Useful To Me  Not Useful To Me

                                                         First   < Newer   1701-1720 of 2134   Older>   Last